Malingering

Abstract

Malingering is a type of behavioral symptom as MeSH indexes it: the intentional feigning or gross exaggeration of symptoms, motivated by an external incentive such as compensation, avoiding duty, or obtaining drugs. Cognitive psychology treats it not as a moral category but as a measurement problem: if a person can deliberately fail a test, any score is a joint product of ability and effort that must be separated before it means anything. This article distinguishes malingering from the factitious and somatoform presentations; sets out the Slick criteria and their multidimensional update; explains the two logics of detection — forced-choice performance-validity testing with its below-chance signature, and symptom-validity scales for implausible self-report; and reviews Rogers’s explanatory models of feigning. A worked example derives a below-chance probability, and three interactive demonstrations make the mechanisms concrete.

Keywords: malingering, performance validity, symptom validity, forced-choice testing, effort

The problem malingering poses to cognitive assessment is sharper than dishonesty in the ordinary sense. Every ability test rests on an unstated assumption — that the examinee is trying — and the whole apparatus of norms, cutoffs, and diagnostic inference collapses if that assumption fails silently. A genuinely amnesic patient and a person feigning amnesia can produce the same raw score; what separates them is not the number but the process that generated it (Larrabee, 2003). The cognitive tradition therefore reframed malingering as a detectable departure from the response process a valid test presupposes, and built instruments whose whole purpose is to measure effort rather than ability.

A terminological distinction frames everything that follows. Malingering is defined by the conjunction of two things — intentional feigning and an external incentive — which is exactly what separates it from the factitious presentation, where symptoms are produced to assume the sick role with no external gain, and from somatoform or conversion presentation, where the symptoms are not intentionally produced at all. These are distinct constructs with distinct evidential requirements, and the detection methods below speak to the feigning, not the motive, which must be established separately (Rogers, Sewell, & Goldstein, 1994).

What Malingering Is

In the vocabulary cognitive psychology inherits from MeSH, malingering names a behavioral symptom defined by intention and motive together: the person produces or exaggerates symptoms deliberately, and does so for an external incentive. Both clauses matter. Deliberate feigning without external gain is the factitious presentation; an external incentive alongside symptoms that are genuinely present, or genuinely involuntary, is not malingering at all. The construct sits at the intersection of a behavior (feigning) and a reason (incentive), and an evaluation that establishes one without the other has not established malingering (Rogers, Sewell, & Goldstein, 1994; McDermott, 2012).

What makes malingering a problem for cognitive psychology rather than for ethics alone is that it defeats the logic of testing from the inside. A neuropsychological test infers an underlying capacity from an observed performance, and that inference is only licensed if the performance reflects the examinee’s best effort. When effort is withheld, the observed score no longer estimates capacity; it estimates whatever the examinee chose to display. The field’s response was not to appeal to clinical intuition — which detects feigning poorly — but to build measurement into the process: dedicated performance-validity and symptom-validity instruments that make the response process itself the object of measurement (Boone, 2009). Table 1 sets out the constructs the detection literature keeps carefully apart.

Malingering is not rare in the settings where it matters. Survey-based estimates of its base rate in medico-legal and disability evaluations place symptom exaggeration and probable malingering in a substantial fraction of cases — high enough that, by the logic of base rates, a positive validity finding carries real diagnostic weight and a routine assumption of good effort is untenable (Mittenberg, Patton, Canyock, & Condit, 2002).

Forced-Choice Testing and the Below-Chance Signature

The cleanest detection logic in the field is also the oldest: the two-alternative forced-choice test, introduced as a symptom-validity procedure for functional sensory and memory complaints before it became a mainstay of cognitive malingering detection (Pankratz, 1979). The examinee is shown a stimulus, then asked to pick it out of two options; across many trials, the key quantity is the proportion correct. The insight that makes the method powerful is that chance sets a floor nobody’s impairment can breach. A person with dense amnesia, who genuinely cannot remember a single item, will still answer about half of a two-choice test correctly simply by guessing. Scoring well below fifty percent is therefore not a sign of bad memory — bad memory cannot do it — but of someone who knew the right answer well enough to avoid it (Larrabee, 2003).

This below-chance result is statistically interpretable. Under genuine impairment the number correct follows a binomial distribution centered on chance, so a score far enough below the midpoint has a small, computable probability of arising honestly; when that probability is tiny, the most economical explanation is deliberate failure. The Worked Example below derives one such probability. In practice few malingerers score below chance — it is a conspicuous giveaway — so modern forced-choice instruments do not rely on it alone. The Test of Memory Malingering, the most widely used of them, instead sets empirically derived cutoffs well above chance, validated by showing that cognitively impaired but genuinely cooperative patients still pass comfortably (Tombaugh, 1997).

The distinction between a chance-based cutoff and an empirical one is worth drawing. The below-chance criterion is logically airtight but insensitive, because it catches only the crudest feigning. An empirical cutoff trades that certainty for sensitivity: it asks not whether a score is impossibly low but whether it is improbably low for someone genuinely trying, calibrated against the performance of real patients with real deficits. The move from the first logic to the second is the move from a statistical curiosity to a clinical instrument (Tombaugh, 1997; Vickery, Berry, Inman, Harris, & Orey, 2001).

Performance Validity and Symptom Validity

The modern literature splits the measurement of effort into two kinds, and the distinction is not cosmetic. A performance-validity test measures whether an examinee’s performance on an ability task is credible — the forced-choice memory tests are the archetype, but the family also includes embedded indicators drawn from standard tests, where an atypical pattern (easy items failed while harder ones pass, or a profile no real disorder produces) signals invalid effort (Larrabee, 2003). A symptom-validity test, by contrast, measures whether an examinee’s self-report of symptoms is credible — typically a questionnaire scale built to detect the over-endorsement of rare, absurd, or implausibly severe complaints that genuine patients seldom report (Rogers, Sewell, Martin, & Vitacco, 2003).

The two detect different things and can disagree, which is a feature rather than a flaw. A person can feign a cognitive deficit while reporting symptoms honestly, or exaggerate distress while performing credibly on ability tasks; the constructs are separable, and a thorough evaluation samples both. Meta-analytic work established that multiple validity indicators, combined, detect inadequate effort with far better accuracy than any single measure, which is why the field moved from a single screening test toward a battery sampling effort continuously across the examination (Vickery, Berry, Inman, Harris, & Orey, 2001; Boone, 2009).

The reliance on self-report instruments has its own canonical tool. The Minnesota Multiphasic Personality Inventory carries validity scales designed to flag feigned psychopathology, and a meta-analysis of their performance showed that feigning groups over-endorse infrequent and implausible content at rates that separate them reliably from both honest patients and the general population — while also cautioning that the cutoffs must be set with the base rate of the setting in mind (Rogers, Sewell, Martin, & Vitacco, 2003).

The Slick Criteria and Their Update

Detection instruments produce evidence; they do not, by themselves, produce a diagnosis. The step that turned a scattered literature into a usable standard was a set of explicit diagnostic criteria. The Slick criteria defined malingered neurocognitive dysfunction by the conjunction of three things: a substantial external incentive, evidence from neuropsychological testing (including below-chance forced-choice performance or other validity failures), and evidence of inconsistency — between test data and known patterns of brain function, between test data and observed behavior, or within the examinee’s own self-report — with the whole not better explained by a psychiatric or developmental condition (Slick, Sherman, & Iverson, 1999).

The criteria mattered because they made the diagnosis a matter of converging, specifiable evidence rather than clinical hunch, and they graded confidence — definite, probable, possible — by how strong that convergence was. They were not without problems: the single-indicator thresholds proved too liberal as more validity tests accumulated, and the possible category was criticized as too easily met. The twenty-year update retained the diathesis — incentive plus feigning plus inconsistency — but recast the evidence multidimensionally, requiring multiple independent validity failures and tightening the confidence levels to reflect what two decades of psychometric work had learned about false-positive rates (Sherman, Slick, & Iverson, 2020).

The same evidential logic extends beyond cognition. Applied to claimed pain-related disability, the criteria become a framework for malingered pain-related disability: an external incentive, physiological or behavioral findings inconsistent with the claimed condition, and performance-validity failure on cognitive testing together support the inference, while no single element carries it (Bianchini, Greve, & Glynn, 2005).

Why People Feign: Explanatory Models

Detecting feigning and explaining it are different tasks, and the explanatory question has its own literature. A prototypical analysis of how experts conceive of malingering distinguished three models. The pathogenic model treats feigning as the product of an underlying disorder — the symptoms are consciously produced but driven by psychopathology. The criminological model, embedded in the DSM, frames malingering as a quasi-criminal act, flagged by an antisocial context, legal involvement, and uncooperativeness. The adaptational model treats feigning as a rational cost-benefit decision: a person in an adversarial situation, perceiving the stakes as high and honest means as unlikely to succeed, chooses to feign (Rogers, Sewell, & Goldstein, 1994).

The adaptational model has been the most influential, because it fits the data better than the others: malingering clusters not where psychopathology is greatest but where incentives are largest and adversarial, which is what a decision-theoretic account predicts. It also reframes detection usefully — if feigning is a response to perceived stakes, then the evaluation context itself shapes the base rate, and a high-incentive forensic setting should raise the examiner’s prior accordingly (Rogers, Sewell, & Goldstein, 1994; McDermott, 2012).

Worked Example: A Below-Chance Probability

Consider a two-alternative forced-choice recognition test of 50 items. An examinee who genuinely cannot remember any item still has a one-in-two chance of answering each correctly by guessing, so under honest responding the number correct follows a binomial distribution with n = 50 and p = 0.5, centered on 25. Suppose the examinee scores 16 correct.

The question is how improbable 16-or-fewer-correct is under honest guessing. The mean of the distribution is np = 50 × 0.5 = 25, and its standard deviation is √(np(1 − p)) = √(50 × 0.5 × 0.5) = √12.5 ≈ 3.54. A score of 16 lies 25 − 16 = 9 correct below the mean, or 9 / 3.54 ≈ 2.55 standard deviations below it.

The exact lower-tail binomial probability of scoring 16 or fewer correct out of 50 under p = 0.5 is approximately 0.0077 — under one percent. By the normal approximation, with a continuity correction, the tail beyond (16.5 − 25) / 3.54 ≈ −2.40 is about 0.0082, agreeing closely. Either way, a genuinely impaired examinee produces a score this low less than one time in a hundred, so the result is significantly below chance: the most economical explanation is that the examinee knew the correct answers well enough to select the wrong ones deliberately. The ForcedChoiceDemo lets the reader vary the score and the test length and watch this tail probability move.

Discussion

The cognitive approach to malingering is a case study in turning a soft clinical judgment into a measurement. For most of its history the detection of feigning rested on the examiner’s impression, which is both unreliable and, worse, overconfident; the field’s advance was to replace the impression with instruments whose statistical properties are known and whose errors can be quantified (Boone, 2009). That reframing carries an ethical charge that the terminology tries to contain: a validity-test failure is a statement about a response process, not a verdict on a person’s character, and the careful separation of feigning (which a test can detect) from motive (which it cannot) is what keeps the inference honest (Slick, Sherman, & Iverson, 1999).

Two cautions recur in the literature. The first is the base-rate problem: the predictive value of any validity test depends on how common malingering is in the setting, so a cutoff calibrated for a high-incentive forensic sample will over-diagnose in a clinic where feigning is rare (Mittenberg, Patton, Canyock, & Condit, 2002). The second is the single-indicator trap: no one test is diagnostic, and the move to multidimensional criteria requiring several independent failures exists precisely to keep false positives acceptably low, because the cost of wrongly labeling a genuine patient a malingerer is severe (Sherman, Slick, & Iverson, 2020).

Current Directions

The last decade has consolidated validity assessment into professional consensus. The American Academy of Clinical Neuropsychology, which first issued a formal statement on the assessment of effort and response bias, updated it to reflect the field’s maturation: validity testing is now framed as a standard, expected component of every neuropsychological evaluation, with multiple performance- and symptom-validity indicators sampled across the examination rather than a single gatekeeping test (Sweet et al., 2021; Heilbronner et al., 2009).

Survey evidence tracks how far that consensus has reached practice. A large survey of North American neuropsychologists found that the great majority now administer dedicated validity tests routinely, though it also documented persistent variation in which tests, how many, and what cutoffs practitioners use — a reminder that a settled principle can still leave the details contested (Martin, Schroeder, & Odland, 2015). A critical review of the rapidly expanding performance-validity literature synthesized this growth, cataloguing the proliferation of freestanding and embedded indicators and pressing the field toward clearer standards for how many are needed and how their results should be combined (Lippa, 2018). A parallel methodological concern sharpened in the same period: the way a validity study defines its criterion groups — who counts as a genuine effort case and who as a feigning one — materially shapes the sensitivity and specificity it reports, so headline accuracy figures are not directly comparable across studies that grouped their samples differently (Schroeder, Martin, Heinrichs, & Baade, 2019). The open questions the current literature works on are of this kind: how many independent validity indicators are enough, how to set cutoffs that hold across cultures and languages, how to make accuracy estimates comparable across differently constructed samples, and how to combine indicators into a single credible probability rather than a count of failures (Sherman, Slick, & Iverson, 2020).

Common Misconceptions

Malingering is the same as a factitious disorder.

No. Both involve deliberately produced symptoms, but malingering requires an external incentive, whereas the factitious presentation is motivated by the internal goal of assuming the sick role with no external gain. The feigning can look identical; the motive is the dividing line (Rogers, Sewell, & Goldstein, 1994).

A failed validity test proves the person is lying.

No. A validity-test failure is evidence about a response process, graded by probability, not a certainty. It must combine with a demonstrated incentive and with inconsistency across the examination before a diagnosis of malingering is warranted, and even then it is stated with a confidence level rather than as proof (Slick, Sherman, & Iverson, 1999).

Experienced clinicians can spot feigning by observation.

Unaided clinical judgment detects feigning poorly and tends to be overconfident. The whole point of performance- and symptom-validity testing is to replace that impression with an instrument whose error rates are known (Boone, 2009).

Scoring below chance is required to prove malingering.

Below-chance performance is strong evidence but rare, because it is an obvious giveaway. Modern tests use empirical cutoffs set well above chance and validated against genuinely impaired patients, catching feigning that never drops below the fifty-percent floor (Tombaugh, 1997).

Glossary

Adaptational model.

— Rogers’s account of feigning as a rational cost-benefit decision made in an adversarial context, where high stakes and distrust of honest means make feigning the chosen strategy.

Base rate.

— The prior probability of malingering in a given setting; it governs the predictive value of any validity test and must be considered before a positive result is interpreted.

Below-chance performance.

— A forced-choice score significantly under the level expected from pure guessing; strong evidence of deliberate failure, since genuine impairment cannot drive a score below chance.

Effort.

— The degree to which an examinee engages a test to the best of their ability; the unstated assumption on which the interpretation of any ability score depends.

Embedded indicator.

— A validity measure derived from an ordinary ability test rather than a dedicated instrument, flagging invalid performance through an atypical pattern no genuine disorder produces.

External incentive.

— A tangible outside gain — compensation, avoidance of duty or prosecution, obtaining drugs — whose presence is a defining requirement for malingering, distinguishing it from the factitious presentation.

Factitious presentation.

— Deliberately produced symptoms motivated by the internal goal of assuming the sick role, with no external incentive; distinct from malingering.

Forced-choice test.

— A test in which the examinee selects a target from two or more alternatives on each trial, allowing performance to be compared against the chance level expected from guessing.

Malingered neurocognitive dysfunction.

— The feigning or exaggeration of cognitive deficit for an external incentive; the target of the Slick diagnostic criteria and their multidimensional update.

Performance-validity test.

— An instrument assessing whether an examinee’s performance on an ability task is credible, as opposed to whether their self-reported symptoms are.

Slick criteria.

— The diagnostic standard for malingered neurocognitive dysfunction, requiring an external incentive, validity-test evidence, and inconsistency, graded as definite, probable, or possible.

Somatoform presentation.

— Physical symptoms that are genuinely experienced and not under voluntary control; distinct from malingering because the symptoms are not intentionally produced.

Symptom-validity test.

— An instrument assessing whether an examinee’s self-report of symptoms is credible, typically by detecting the over-endorsement of rare or implausible complaints.

Test of Memory Malingering.

— A widely used forced-choice recognition test with empirically derived cutoffs set well above chance and validated so that genuinely impaired but cooperative patients still pass.

Key Researchers

Kyle Brauer Boone

(Alliant International University; private practice, Torrance, California). Argued for the continuous, comprehensive sampling of effort and response bias throughout a neuropsychological examination rather than a single screening test, and edited major reference volumes on the assessment of noncredible performance.

Faculty profile: kyleboonephd.com/credentials

Grant L. Iverson

(Harvard Medical School; Spaulding Rehabilitation Hospital). Co-author of the Slick criteria and their twenty-year multidimensional update, and a leading figure in the development of performance- and symptom-validity research.

Google Scholar: scholar.google.com/citations?user=IhTQdCoAAAAJ

Richard Rogers

(University of North Texas). Developed the explanatory (adaptational, pathogenic, criminological) models of malingering and the Structured Interview of Reported Symptoms, and conducted the meta-analysis of MMPI-2 feigning detection.

Faculty profile: pahs.unt.edu/psychology/people/richard-rogers

Thomas N. Tombaugh

(d. 2008; Carleton University, emeritus). Author of the Test of Memory Malingering, the forced-choice performance-validity test whose normative work is among the most cited in the field.

Memorial: Dr. Tom Tombaugh Memorial Scholarship, Carleton University

Frequently Asked Questions

What is malingering?

Malingering is the intentional production or gross exaggeration of physical or psychological symptoms, motivated by an external incentive such as financial compensation, avoiding military duty or criminal prosecution, or obtaining drugs. Both the deliberate feigning and the external motive are required for the definition.

How is malingering different from a factitious disorder?

Both involve deliberately produced symptoms, but they differ in motive. Malingering is driven by an external incentive; the factitious presentation is driven by the internal goal of assuming the sick role, with no external gain. The feigning behavior can be identical, so establishing the motive is what separates the two.

How do psychologists detect malingering?

They use dedicated validity tests. Performance-validity tests assess whether performance on an ability task is credible — often through forced-choice recognition, where scoring below chance signals deliberate failure. Symptom-validity tests assess whether self-reported symptoms are credible, typically by detecting the over-endorsement of rare or implausible complaints. Multiple indicators are combined because no single test is diagnostic.

Why does scoring below chance matter?

On a two-alternative forced-choice test, even a genuinely impaired examinee who cannot remember anything will answer about half the items correctly by guessing. Scoring significantly below fifty percent is therefore not something impairment can produce; it indicates that the examinee knew the correct answers well enough to select the wrong ones deliberately.

What are the Slick criteria?

The Slick criteria are a diagnostic standard for malingered neurocognitive dysfunction. They require a substantial external incentive, evidence from validity testing, and evidence of inconsistency across the examination, with the picture not better explained by another condition. Confidence is graded as definite, probable, or possible, and a twenty-year update recast the evidence requirement multidimensionally.

How common is malingering?

It is uncommon in ordinary clinical settings with no external incentive, but base-rate estimates in medico-legal and disability evaluations place symptom exaggeration and probable malingering in a substantial minority of cases. Because the base rate governs how a positive validity result should be interpreted, it must be weighed before any diagnosis.

Can an experienced clinician just tell when someone is faking?

No. Unaided clinical judgment detects feigning poorly and tends toward overconfidence. The reason the field developed performance- and symptom-validity instruments was precisely to replace subjective impression with measurement whose error rates are known and quantifiable.

Does a failed validity test prove someone is malingering?

No. A validity-test failure is probabilistic evidence about a response process, not proof. A diagnosis of malingering requires that evidence to converge with a demonstrated external incentive and with inconsistency across the examination, and it is still expressed with a confidence level rather than as certainty.

References

Bianchini, K. J., Greve, K. W., & Glynn, G. (2005). On the diagnosis of malingered pain-related disability: Lessons from cognitive malingering research. The Spine Journal, 5(4), 404–417. https://doi.org/10.1016/j.spinee.2004.11.016

Boone, K. B. (2009). The need for continuous and comprehensive sampling of effort/response bias during neuropsychological examinations. The Clinical Neuropsychologist, 23(4), 729–741. https://doi.org/10.1080/13854040802427803

Heilbronner, R. L., Sweet, J. J., Morgan, J. E., Larrabee, G. J., & Millis, S. R. (2009). American Academy of Clinical Neuropsychology Consensus Conference Statement on the neuropsychological assessment of effort, response bias, and malingering. The Clinical Neuropsychologist, 23(7), 1093–1129. https://doi.org/10.1080/13854040903155063

Larrabee, G. J. (2003). Detection of malingering using atypical performance patterns on standard neuropsychological tests. The Clinical Neuropsychologist, 17(3), 410–425. https://doi.org/10.1076/clin.17.3.410.18089

Lippa, S. M. (2018). Performance validity testing in neuropsychology: A clinical guide, critical review, and update on a rapidly evolving literature. The Clinical Neuropsychologist, 32(3), 391–421. https://doi.org/10.1080/13854046.2017.1406146

Martin, P. K., Schroeder, R. W., & Odland, A. P. (2015). Neuropsychologists’ validity testing beliefs and practices: A survey of North American professionals. The Clinical Neuropsychologist, 29(6), 741–776. https://doi.org/10.1080/13854046.2015.1087597

McDermott, B. E. (2012). Psychological testing and the assessment of malingering. Psychiatric Clinics of North America, 35(4), 855–876. https://doi.org/10.1016/j.psc.2012.08.006

Mittenberg, W., Patton, C., Canyock, E. M., & Condit, D. C. (2002). Base rates of malingering and symptom exaggeration. Journal of Clinical and Experimental Neuropsychology, 24(8), 1094–1102. https://doi.org/10.1076/jcen.24.8.1094.8379

Pankratz, L. (1979). Symptom validity testing and symptom retraining: Procedures for the assessment and treatment of functional sensory deficits. Journal of Consulting and Clinical Psychology, 47(2), 409–410. https://doi.org/10.1037/0022-006X.47.2.409

Rogers, R., Sewell, K. W., & Goldstein, A. M. (1994). Explanatory models of malingering: A prototypical analysis. Law and Human Behavior, 18(5), 543–552. https://doi.org/10.1007/BF01499173

Rogers, R., Sewell, K. W., Martin, M. A., & Vitacco, M. J. (2003). Detection of feigned mental disorders: A meta-analysis of the MMPI-2 and malingering. Assessment, 10(2), 160–177. https://doi.org/10.1177/1073191103010002007

Schroeder, R. W., Martin, P. K., Heinrichs, R. J., & Baade, L. E. (2019). Research methods in performance validity testing studies: Criterion grouping approach impacts study outcomes. The Clinical Neuropsychologist, 33(3), 466–477. https://doi.org/10.1080/13854046.2018.1484517

Sherman, E. M. S., Slick, D. J., & Iverson, G. L. (2020). Multidimensional malingering criteria for neuropsychological assessment: A 20-year update of the malingered neuropsychological dysfunction criteria. Archives of Clinical Neuropsychology, 35(6), 735–764. https://doi.org/10.1093/arclin/acaa019

Slick, D. J., Sherman, E. M. S., & Iverson, G. L. (1999). Diagnostic criteria for malingered neurocognitive dysfunction: Proposed standards for clinical practice and research. The Clinical Neuropsychologist, 13(4), 545–561. https://doi.org/10.1076/1385-4046(199911)13:04;1-y;ft545

Sweet, J. J., Heilbronner, R. L., Morgan, J. E., Larrabee, G. J., Rohling, M. L., Boone, K. B., Kirkwood, M. W., Schroeder, R. W., & Suhr, J. A. (2021). American Academy of Clinical Neuropsychology (AACN) 2021 consensus statement on validity assessment: Update of the 2009 AACN consensus conference statement on neuropsychological assessment of effort, response bias, and malingering. The Clinical Neuropsychologist, 35(6), 1053–1106. https://doi.org/10.1080/13854046.2021.1896036

Tombaugh, T. N. (1997). The Test of Memory Malingering (TOMM): Normative data from cognitively intact and cognitively impaired individuals. Psychological Assessment, 9(3), 260–268. https://doi.org/10.1037/1040-3590.9.3.260

Vickery, C. D., Berry, D. T. R., Inman, T. H., Harris, M. J., & Orey, S. A. (2001). Detection of inadequate effort on neuropsychological testing: A meta-analytic review of selected procedures. Archives of Clinical Neuropsychology, 16(1), 45–73. https://doi.org/10.1016/S0887-6177(99)00058-X